CERA

Science and Research

HUMBOLDT: Efficacy and Safety of Filgotinib in Subjects with Active Non-Infectious Uveitis

This study is designed to demonstrate the efficacy and safety of filgotinib in subjects requiring high dose steroids for active non-infectious uveitis.

Overview

This is a randomised, masked, placebo-controlled Phase II trial in subjects with active non-infectious uveitis, despite at least two weeks of maintenance therapy with oral prednisolone.

The study is designed to demonstrate the efficacy and safety of filgotinib in subjects requiring high dose steroids for active non-infectious uveitis.

  • Principal Investigator
Associate Professor Lyndell Lim

Learn more

View this study at ClinicalTrials.gov

This international database listing provides more detailed information about this study.